Your browser doesn't support javascript.
loading
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma.
Martello, M; Poletti, A; Borsi, E; Solli, V; Dozza, L; Barbato, S; Zamagni, E; Tacchetti, P; Pantani, L; Mancuso, K; Vigliotta, I; Rizzello, I; Rocchi, S; Armuzzi, S; Testoni, N; Marzocchi, G; Martinelli, G; Cavo, M; Terragna, C.
Afiliación
  • Martello M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Poletti A; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Borsi E; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Solli V; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Dozza L; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Barbato S; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Zamagni E; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Tacchetti P; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Pantani L; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Mancuso K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Vigliotta I; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Rizzello I; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Rocchi S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Armuzzi S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Testoni N; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Marzocchi G; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Martinelli G; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
  • Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.
  • Terragna C; Department of Experimental, Diagnostic and Specialty Medicine - University of Bologna, Bologna, Italy.
Blood Cancer J ; 12(1): 15, 2022 01 26.
Article en En | MEDLINE | ID: mdl-35082295
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Polimorfismo de Nucleótido Simple / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Polimorfismo de Nucleótido Simple / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos